Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Vaccine. 2013 Oct 1;31(42):4744-8. doi: 10.1016/j.vaccine.2013.08.022. Epub 2013 Aug 20.
Varicella vaccine was introduced to the infant immunization schedule in each province or territory between 2000 and 2007 as a result of the Canadian Immunization Strategy. The impact of vaccinating children against this disease is potentially far reaching, as immunization may also benefit those segments of the population not immunized. The objective of this paper is to examine the effects of varicella vaccine on related hospitalizations across the entire Canadian population.
This study is an ecological study using annual hospitalization rates in all ten provinces between 1990 and 2010.
There were decreased varicella-related hospitalization rates for all ages across Canada following the introduction of varicella vaccination programs. The majority of changes in hospitalization rates were greater than 70% across all ages less than 40. Statistically significant declines in hospitalization were found for children aged 1-4 (ranges from 65 to 93%), and children less than 1 (ranges from 48 to 100%). Adults aged 20-39 and 40-59 also experienced statistically significant declines (55-100%, and 39-76% respectively).
Results suggest that decreased circulation of varicella appears to significantly contribute to declines in varicella-related hospitalizations for infants <1, as well as adults aged 20-39.
由于加拿大免疫策略,2000 年至 2007 年间,各省和地区相继将水痘疫苗纳入婴儿免疫计划。接种儿童疫苗预防这种疾病的影响可能是深远的,因为免疫也可能使未免疫的人群受益。本文的目的是研究水痘疫苗对全加人口相关住院治疗的影响。
本研究是一项采用 1990 年至 2010 年 10 个省的年度住院率的生态学研究。
在引入水痘疫苗接种计划后,加拿大所有年龄段的水痘相关住院率均有所下降。所有年龄组(小于 40 岁)的住院率变化中,超过 70%的变化幅度较大。1-4 岁儿童(65%至 93%)和 1 岁以下儿童(48%至 100%)的住院率下降具有统计学意义。20-39 岁和 40-59 岁的成年人也经历了显著的下降(55%-100%和 39%-76%)。
结果表明,水痘的流通减少似乎显著导致 1 岁以下婴儿以及 20-39 岁成年人的水痘相关住院率下降。